OBJECTIVES: To determine the incidence and association of myocardial ischemia with troponin elevation and survival in high-cardiac-risk intensive care patients. DESIGN: Prospective observational study. SETTING: Intensive care unit of a tertiary hospital. SUBJECTS: One-hundred one general intensive care unit patients having a history of coronary artery disease or at least two risk factors for coronary artery disease. INTERVENTIONS: Continuous 12-lead electrocardiographic monitoring with on-line ST-trend analysis, daily cardiac troponin measurements, clinical and physiologic assessment, and up to 2-yr follow-up for survival. MEASUREMENTS AND MAIN RESULTS: During 8,988 hrs or a mean +/- sd of 95 +/- 85 hrs/patient of continuous 12-lead electrocardiographic monitoring, 21 patients (21%) had ischemic ST-segment changes, characterized in most (19) by ST depression and lasting >60 mins in 15 (71.4%). Of the 38 patients (38%) with troponin elevation, myocardial infarction was clinically suspected in four and myocardial ischemia on continuous 12-lead electrocardiographic monitoring was observed in 14 (36.8%). Fourteen (66.7%) of the patients with ischemic ST changes and 12 (75%) of those with prolonged (>60 mins) ischemia had troponin elevation. The sensitivity, specificity, and positive and negative predictive values of prolonged (>60 mins) ischemia predicting troponin elevation were 31.6%, 95.2%, 80.0%, and 69.8%, respectively. Prolonged (>60 mins) ischemia was significantly associated with troponin elevation by both univariate and multivariate analyses (odds ratio = 9.0; p = .008). Acute Physiology and Chronic Health Evaluation II score, renal failure, and the use of norepinephrine also independently predicted troponin elevation. Troponin but not ischemia predicted increased 1-month, 6-month, and 2-yr mortality (odds ratio = 6.0, 3.2, and 2.99, respectively; p < .001). CONCLUSIONS: Silent ischemia is strongly associated with troponin elevation in high-cardiac-risk intensive care unit patients, and troponin elevation predicts both early and late mortality.
OBJECTIVES: To determine the incidence and association of myocardial ischemia with troponin elevation and survival in high-cardiac-risk intensive care patients. DESIGN: Prospective observational study. SETTING: Intensive care unit of a tertiary hospital. SUBJECTS: One-hundred one general intensive care unit patients having a history of coronary artery disease or at least two risk factors for coronary artery disease. INTERVENTIONS: Continuous 12-lead electrocardiographic monitoring with on-line ST-trend analysis, daily cardiac troponin measurements, clinical and physiologic assessment, and up to 2-yr follow-up for survival. MEASUREMENTS AND MAIN RESULTS: During 8,988 hrs or a mean +/- sd of 95 +/- 85 hrs/patient of continuous 12-lead electrocardiographic monitoring, 21 patients (21%) had ischemic ST-segment changes, characterized in most (19) by ST depression and lasting >60 mins in 15 (71.4%). Of the 38 patients (38%) with troponin elevation, myocardial infarction was clinically suspected in four and myocardial ischemia on continuous 12-lead electrocardiographic monitoring was observed in 14 (36.8%). Fourteen (66.7%) of the patients with ischemic ST changes and 12 (75%) of those with prolonged (>60 mins) ischemia had troponin elevation. The sensitivity, specificity, and positive and negative predictive values of prolonged (>60 mins) ischemia predicting troponin elevation were 31.6%, 95.2%, 80.0%, and 69.8%, respectively. Prolonged (>60 mins) ischemia was significantly associated with troponin elevation by both univariate and multivariate analyses (odds ratio = 9.0; p = .008). Acute Physiology and Chronic Health Evaluation II score, renal failure, and the use of norepinephrine also independently predicted troponin elevation. Troponin but not ischemia predicted increased 1-month, 6-month, and 2-yr mortality (odds ratio = 6.0, 3.2, and 2.99, respectively; p < .001). CONCLUSIONS: Silent ischemia is strongly associated with troponin elevation in high-cardiac-risk intensive care unit patients, and troponin elevation predicts both early and late mortality.
Authors: Marc D Berg; Isabelle L Banville; Fred W Chapman; Robert G Walker; Mohammed A Gaballa; Ronald W Hilwig; Ricardo A Samson; Karl B Kern; Robert A Berg Journal: Pediatr Crit Care Med Date: 2008-07 Impact factor: 3.624
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White Journal: Nat Rev Cardiol Date: 2012-08-25 Impact factor: 32.419
Authors: Giora Landesberg; Dan Gilon; Yuval Meroz; Milena Georgieva; Phillip D Levin; Sergey Goodman; Alexander Avidan; Ronen Beeri; Charles Weissman; Allan S Jaffe; Charles L Sprung Journal: Eur Heart J Date: 2011-09-11 Impact factor: 29.983
Authors: Nathaniel R Smilowitz; Matthew C Weiss; Rina Mauricio; Asha M Mahajan; Kaitlyn E Dugan; Arvind Devanabanda; Claudia Pulgarin; Eugenia Gianos; Binita Shah; Steven P Sedlis; Martha Radford; Harmony R Reynolds Journal: Int J Cardiol Date: 2016-05-13 Impact factor: 4.164
Authors: Nathaniel R Smilowitz; Gabriel Redel-Traub; Anais Hausvater; Andrew Armanious; Joseph Nicholson; Christian Puelacher; Jeffrey S Berger Journal: Cardiol Rev Date: 2019 Nov/Dec Impact factor: 2.644
Authors: Jessica P Simons; Donald T Baril; Philip P Goodney; Daniel J Bertges; William P Robinson; Jack L Cronenwett; Louis M Messina; Andres Schanzer Journal: J Vasc Surg Date: 2013-08-01 Impact factor: 4.268